Renal Data from the Arab World Dialysis in Kuwait: 2013-2019
Affiliations
Affiliations
- Division of Nephrology, Jahra Hospital, Jahra, Kuwait.
- Division of Nephrology, Adan Hospital, Hadiya, Kuwait.
- Division of Nephrology, Amiri Hospital, Kuwait City, Kuwait.
- Division of Nephrology, Mubarak Hospital, Jabriya, Kuwait.
- Division of Nephrology, Farwaniya Hospital, Sabah Al Nasser, Kuwait.
- Division of Pediatric Nephrology, Mubarak Hospital, Jabriya, Kuwait.
- Department of Medical Laboratories Faculty of Allied Health Sciences Kuwait University, Jabriya; Department of Genetics and Bioinformatics, Dasman Diabetes Institute, Kuwait.
Abstract
The total number of end-stage kidney disease patients treated with dialysis in 2019 in Kuwait was 2230, with a 6% increase from the year before. Dialysis prevalence was 465 per million population (PMP) and dialysis incidence was100 PMP. Kuwaiti nationals represented 70% of the dialysis population and males represented 52%. Of the same population, 59% had diabetes. Hepatitis C virus affected <4% and hepatitis B virus affected <2% of the dialysis population. The annual mortality rate was stable at around 12%. Hemodialysis (HD) share was 89%, with 48% of HD patients getting HD via catheter, 54% on hemodiafiltration (HDF), and 50% dialyzing against a calcium bath of 1.75. Patients getting <3 times/week of HD constituted 10% and patients spending <3.5 h/session constituted 11%. We had only 20 dialysis patients under the age of 12 years (12 on HD). The major challenges faced included poor peritoneal dialysis penetration, the unacceptable high rates of catheters as primary HD vascular access, partly due to lack of chronic kidney disease (CKD) clinics and lack of vascular access coordinators, and the unexplained high rates of use of calcium bath of 1.75. There is also a need for a national campaign for early detection and prevention of CKD to reduce rates of end-stage renal disease.
Similar articles
Couchoud C, Lassalle M, Jacquelinet C.Nephrol Ther. 2013 Sep;9 Suppl 1:S3-6. doi: 10.1016/S1769-7255(13)70036-1.PMID: 24119584 French.
[The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
Antonucci F, Camerin E, Feriani M, Nordio M, Piccoli A, Rossi B, Tessitore N.G Ital Nefrol. 2009 Nov-Dec;26 Suppl 48:S5-56.PMID: 19927265 Italian.
AlYousef A, AlGhareeb S, Al Wakeel J, Al-Ghamdi SM, Bieber BA, Hassan M, Al Maimani Y, Alkandari N, Ahmed HZ, Fawzy A, Pisoni RL; GCC-DOPPS 5 Study Group.Saudi J Kidney Dis Transpl. 2016 Nov;27(6 Suppl 1):S42-50. doi: 10.4103/1319-2442.194889.PMID: 27991478
Clinical evaluation indices for hemodialysis/hemodiafiltration in Japan.
Shinoda T, Koda Y.Contrib Nephrol. 2011;168:173-178. doi: 10.1159/000321758. Epub 2010 Oct 7.PMID: 20938138 Review.
Jungers P, Robino C, Choukroun G, Touam M, Fakhouri F, Grünfeld JP.Nephrologie. 2001;22(3):91-7.PMID: 11436669 Review. French.
Cited by
The genetic landscape of autosomal dominant polycystic kidney disease in Kuwait.
Ali H, Naim M, Senum SR, AlSahow A, Bahbahani Y, Abu-Farha M, Abubaker J, Mohammad A, Al-Hunayan A, Asbeutah AM, Zayed M, Devarajan S, Hussain N, John SE, Channanath A, Thanaraj TA, Al-Ali M, AlMousawi M, Al-Mulla F, Harris PC.Clin Kidney J. 2022 Oct 28;16(2):355-366. doi: 10.1093/ckj/sfac236. eCollection 2023 Feb.PMID: 36755831 Free PMC article.
Global Dialysis Perspective: Kuwait.
AlSahow A, AlYousef A.Kidney360. 2021 Apr 7;2(6):1015-1020. doi: 10.34067/KID.0000392021. eCollection 2021 Jun 24.PMID: 35373073 Free PMC article. No abstract available.
Ali H, Abu-Farha M, Alshawaf E, Devarajan S, Bahbahani Y, Al-Khairi I, Cherian P, Alsairafi Z, Vijayan V, Al-Mulla F, Al Attar A, Abubaker J.BMC Nephrol. 2022 Feb 11;23(1):64. doi: 10.1186/s12882-022-02692-z.PMID: 35148702 Free PMC article.